Wall Street Analysts Believe Arcutis Biotherapeutics (ARQT) Could Rally 101.09%: Here's is How to Trade

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $9.20, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 18.50 indicates a 101.1% upside potential. The mean estimate comprises six short-term price targets with a standard deviation of $4.81. While the lowest estimate of$ 11 indicates a 19.6% increase from the current price level, the most optimist ...